Advertisement
Screener

C3.ai, Inc. (AI) Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

2.3 / 5 stars · 20/43 Roast Me

C3.ai, Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount

C3.ai, Inc. (AI) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2022-04-30, per its 10-K filed 2022-06-23.

Discontinued › Operating Expenses

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2022-06-23

  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-04-30 was $0.00, a 100.00% decline year-over-year.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2021-01-31 was $0.00.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2020-04-30 was $1.02M.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2020-01-31 was $0.00.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2020 was $1.02M.
  • C3.ai, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2019 was $0.00.
Period endEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month
2022-04-30$0.00
10-K · filed 2022-06-23
2021-04-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23
$0.00
derived: sum of 2 quarters · filed 2022-06-23
$0.00
10-K · filed 2022-06-23
2021-01-31$0.00
10-Q · filed 2021-03-02
$0.00
10-Q · filed 2021-03-02
2020-04-30$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23
$1.02M
derived: sum of 2 quarters · filed 2022-06-23
$1.02M
10-K · filed 2022-06-23
2020-01-31$0.00
10-Q · filed 2021-03-02
$0.00
10-Q · filed 2021-03-02
2019-04-30$0.00
10-K · filed 2021-06-25